Cite
Vallo S, Michaelis M, Rothweiler F, et al. Drug-Resistant Urothelial Cancer Cell Lines Display Diverse Sensitivity Profiles to Potential Second-Line Therapeutics. Transl Oncol. 2015;8(3):210-6doi: 10.1016/j.tranon.2015.04.002.
Vallo, S., Michaelis, M., Rothweiler, F., Bartsch, G., Gust, K. M., Limbart, D. M., Rödel, F., Wezel, F., Haferkamp, A., & Cinatl, J. (2015). Drug-Resistant Urothelial Cancer Cell Lines Display Diverse Sensitivity Profiles to Potential Second-Line Therapeutics. Translational oncology, 8(3), 210-6. https://doi.org/10.1016/j.tranon.2015.04.002
Vallo, Stefan, et al. "Drug-Resistant Urothelial Cancer Cell Lines Display Diverse Sensitivity Profiles to Potential Second-Line Therapeutics." Translational oncology vol. 8,3 (2015): 210-6. doi: https://doi.org/10.1016/j.tranon.2015.04.002
Vallo S, Michaelis M, Rothweiler F, Bartsch G, Gust KM, Limbart DM, Rödel F, Wezel F, Haferkamp A, Cinatl J. Drug-Resistant Urothelial Cancer Cell Lines Display Diverse Sensitivity Profiles to Potential Second-Line Therapeutics. Transl Oncol. 2015 Jun;8(3):210-6. doi: 10.1016/j.tranon.2015.04.002. PMID: 26055179; PMCID: PMC4487788.
Copy
Download .nbib
